Form 13-F position report

HEALTHEQUITY INC

Reported by GENEVA CAPITAL MANAGEMENT LLC

HQY CUSIP 42226A107 Manager CIK 0001009232

Reported 1,108,241 shares, up 64,487 (6.2%) from the prior quarter.

Reported value 25.9%; share count 6.2% vs. the prior quarter.

Added
% of reported 13F value 1.94% This manager · Q2 2025
Shares 1,108,241 Quarter-end amount reported
Reported value $116,099,294 Fair value at quarter end
Consecutive quarters held 22 Through Q2 2025

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 36338000
2022-03-31 57859000
2022-06-30 52199000
2022-09-30 58887000
2022-12-31 53491069
2023-03-31 51748237
2023-06-30 55172550
2023-09-30 64017227
2023-12-31 57729730
2024-03-31 70656114
2024-06-30 72525978
2024-09-30 68918397
2024-12-31 100642274
2025-03-31 92236580
2025-06-30 116099294
2025-09-30 104020170
2025-12-31 102472720
2026-03-31 98117013
2026-06-30 103839080
2026-09-30 97842638

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for HEALTHEQUITY INC held by GENEVA CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 1,106,066 -43,614 (-3.8%) 2.73% $97,842,638 2026-11-09
Q2 2026 Reduced 1,149,680 -24,390 (-2.1%) 2.38% $103,839,080 2026-08-06
Q1 2026 Added 1,174,070 +55,494 (5.0%) 2.09% $98,117,013 2026-05-06
Q4 2025 Added 1,118,576 +20,969 (1.9%) 1.92% $102,472,720 2026-02-12
Q3 2025 Reduced 1,097,607 -10,634 (-1.0%) 1.78% $104,020,170 2025-11-13
Q2 2025 Added 1,108,241 +64,487 (6.2%) 1.94% $116,099,294 2025-08-05
Q1 2025 Reduced 1,043,754 -5,149 (-0.5%) 1.72% $92,236,580 2025-05-09
Q4 2024 Added 1,048,903 +206,894 (24.6%) 1.75% $100,642,274 2025-02-06
Q3 2024 Added 842,009 +640 (0.1%) 1.15% $68,918,397 2024-11-05
Q2 2024 Reduced 841,369 -24,197 (-2.8%) 1.32% $72,525,978 2024-08-14
Q1 2024 Reduced 865,566 -5,169 (-0.6%) 1.24% $70,656,114 2024-05-03
Q4 2023 Reduced 870,735 -5,613 (-0.6%) 1.09% $57,729,730 2024-02-07
Q3 2023 Added 876,348 +2,535 (0.3%) 1.35% $64,017,227 2023-11-13
Q2 2023 Reduced 873,813 -7,608 (-0.9%) 1.09% $55,172,550 2023-08-01
Q1 2023 Added 881,421 +13,623 (1.6%) 1.05% $51,748,237 2023-05-15
Q4 2022 Reduced 867,798 -8,893 (-1.0%) 1.2% $53,491,069 2023-02-07
Q3 2022 Added 876,691 +26,414 (3.1%) 1.36% $58,887,000 2022-11-02
Q2 2022 Reduced 850,277 -7,641 (-0.9%) 1.2% $52,199,000 2022-08-02
Q1 2022 Added 857,918 +36,520 (4.4%) 1.12% $57,859,000 2022-05-02
Q4 2021 Reduced 821,398 -66,492 (-7.5%) 0.59% $36,338,000 2022-02-02
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

540 managers reported HEALTHEQUITY INC for Q2 2025.

Managers reporting HEALTHEQUITY INC in Q2 2025.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 10,723,982 -144,118 0.02% $1,123,444,355 4 qtrs
VANGUARD GROUP INC Reduced 8,502,706 -319,132 0.01% $890,743,481 44 qtrs
WASATCH ADVISORS INC Reduced 6,101,064 -1,132,972 3.35% $639,147,465 44 qtrs
FMR LLC Added 5,040,016 +54,803 0.03% $527,992,039 35 qtrs
STATE STREET CORPORATION Reduced 3,184,220 -95,848 0.01% $333,578,887 44 qtrs
Invesco Ltd Reduced 2,365,860 -80,338 0.04% $247,847,538 41 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 2,147,178 +4,386 0.02% $224,965,230 44 qtrs
BROWN ADVISORY INC Reduced 1,627,024 -305,906 0.22% $170,447,083 30 qtrs
DIMENSIONAL FUND ADVISORS LP Reduced 1,520,854 -12,519 0.04% $159,325,353 36 qtrs
MORGAN STANLEY Reduced 1,404,168 -3,126 < 0.01% $147,100,818 44 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
June 30, 2025
Filed
August 05, 2025
Filing type
13F-HR
Position type
COMMON-STOCK

Voting authority reported

Sole
1,055,591
Shared
0
None
52,650

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.